Insulin growth factors may explain relationship between spasticity and skeletal muscle size in men with spinal cord injury

Ashraf S. Gorgey, David R. Gater

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The major objectives of this cross-sectional study were to (1) measure insulin-like growth factor-1 (IGF-1) in individuals with complete spinal cord injury (SCI) and spasticity and (2) determine the relationships between IGF-1 and cross-sectional areas (CSAs) of thigh skeletal muscle groups. Eight individuals with motor complete SCI underwent magnetic resonance imaging to measure the CSA of the whole thigh, knee extensor, and knee flexor skeletal muscle groups and dual-emission X-ray absorptiometry to measure fat-free mass. After participants fasted for 12 h, we measured their IGF-1 levels and determined spasticity using the Modified Ashworth Scale (MAS). Spearman rho correlations were used to test for the relationships among the tested variables, and independent t-tests were used to determine the difference in plasma IGF-1. Plasma IGF-1 was 44% greater in those with MAS scores of 2 or higher (p < 0.05). Plasma IGF-1 was positively related to knee extensor skeletal muscle CSA (r = 0. 83, p < 0.01). IGF-1 was strongly related to knee extensor and flexor spasticity (r = 0.88, p < 0.004). The findings suggest that IGF-1 is greater in SCI individuals with increased spasticity, and this may explain the strong positive relationships that were noted between spasticity and skeletal muscle CSA.

Original languageEnglish (US)
Pages (from-to)373-380
Number of pages8
JournalJournal of Rehabilitation Research and Development
Volume49
Issue number3
DOIs
StatePublished - Dec 11 2012

Fingerprint

Somatomedins
Spinal Cord Injuries
Intercellular Signaling Peptides and Proteins
Skeletal Muscle
Insulin
Knee
Thigh
Photon Absorptiometry
Cross-Sectional Studies
Fats
Magnetic Resonance Imaging

All Science Journal Classification (ASJC) codes

  • Rehabilitation

Cite this

@article{d5ce40b8bbf34353852017cf59a58373,
title = "Insulin growth factors may explain relationship between spasticity and skeletal muscle size in men with spinal cord injury",
abstract = "The major objectives of this cross-sectional study were to (1) measure insulin-like growth factor-1 (IGF-1) in individuals with complete spinal cord injury (SCI) and spasticity and (2) determine the relationships between IGF-1 and cross-sectional areas (CSAs) of thigh skeletal muscle groups. Eight individuals with motor complete SCI underwent magnetic resonance imaging to measure the CSA of the whole thigh, knee extensor, and knee flexor skeletal muscle groups and dual-emission X-ray absorptiometry to measure fat-free mass. After participants fasted for 12 h, we measured their IGF-1 levels and determined spasticity using the Modified Ashworth Scale (MAS). Spearman rho correlations were used to test for the relationships among the tested variables, and independent t-tests were used to determine the difference in plasma IGF-1. Plasma IGF-1 was 44{\%} greater in those with MAS scores of 2 or higher (p < 0.05). Plasma IGF-1 was positively related to knee extensor skeletal muscle CSA (r = 0. 83, p < 0.01). IGF-1 was strongly related to knee extensor and flexor spasticity (r = 0.88, p < 0.004). The findings suggest that IGF-1 is greater in SCI individuals with increased spasticity, and this may explain the strong positive relationships that were noted between spasticity and skeletal muscle CSA.",
author = "Gorgey, {Ashraf S.} and Gater, {David R.}",
year = "2012",
month = "12",
day = "11",
doi = "10.1682/JRRD.2011.04.0076",
language = "English (US)",
volume = "49",
pages = "373--380",
journal = "Journal of rehabilitation R&D",
issn = "0748-7711",
publisher = "Rehabilitation Research and Development Service",
number = "3",

}

Insulin growth factors may explain relationship between spasticity and skeletal muscle size in men with spinal cord injury. / Gorgey, Ashraf S.; Gater, David R.

In: Journal of Rehabilitation Research and Development, Vol. 49, No. 3, 11.12.2012, p. 373-380.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Insulin growth factors may explain relationship between spasticity and skeletal muscle size in men with spinal cord injury

AU - Gorgey, Ashraf S.

AU - Gater, David R.

PY - 2012/12/11

Y1 - 2012/12/11

N2 - The major objectives of this cross-sectional study were to (1) measure insulin-like growth factor-1 (IGF-1) in individuals with complete spinal cord injury (SCI) and spasticity and (2) determine the relationships between IGF-1 and cross-sectional areas (CSAs) of thigh skeletal muscle groups. Eight individuals with motor complete SCI underwent magnetic resonance imaging to measure the CSA of the whole thigh, knee extensor, and knee flexor skeletal muscle groups and dual-emission X-ray absorptiometry to measure fat-free mass. After participants fasted for 12 h, we measured their IGF-1 levels and determined spasticity using the Modified Ashworth Scale (MAS). Spearman rho correlations were used to test for the relationships among the tested variables, and independent t-tests were used to determine the difference in plasma IGF-1. Plasma IGF-1 was 44% greater in those with MAS scores of 2 or higher (p < 0.05). Plasma IGF-1 was positively related to knee extensor skeletal muscle CSA (r = 0. 83, p < 0.01). IGF-1 was strongly related to knee extensor and flexor spasticity (r = 0.88, p < 0.004). The findings suggest that IGF-1 is greater in SCI individuals with increased spasticity, and this may explain the strong positive relationships that were noted between spasticity and skeletal muscle CSA.

AB - The major objectives of this cross-sectional study were to (1) measure insulin-like growth factor-1 (IGF-1) in individuals with complete spinal cord injury (SCI) and spasticity and (2) determine the relationships between IGF-1 and cross-sectional areas (CSAs) of thigh skeletal muscle groups. Eight individuals with motor complete SCI underwent magnetic resonance imaging to measure the CSA of the whole thigh, knee extensor, and knee flexor skeletal muscle groups and dual-emission X-ray absorptiometry to measure fat-free mass. After participants fasted for 12 h, we measured their IGF-1 levels and determined spasticity using the Modified Ashworth Scale (MAS). Spearman rho correlations were used to test for the relationships among the tested variables, and independent t-tests were used to determine the difference in plasma IGF-1. Plasma IGF-1 was 44% greater in those with MAS scores of 2 or higher (p < 0.05). Plasma IGF-1 was positively related to knee extensor skeletal muscle CSA (r = 0. 83, p < 0.01). IGF-1 was strongly related to knee extensor and flexor spasticity (r = 0.88, p < 0.004). The findings suggest that IGF-1 is greater in SCI individuals with increased spasticity, and this may explain the strong positive relationships that were noted between spasticity and skeletal muscle CSA.

UR - http://www.scopus.com/inward/record.url?scp=84866436030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866436030&partnerID=8YFLogxK

U2 - 10.1682/JRRD.2011.04.0076

DO - 10.1682/JRRD.2011.04.0076

M3 - Article

C2 - 22773197

AN - SCOPUS:84866436030

VL - 49

SP - 373

EP - 380

JO - Journal of rehabilitation R&D

JF - Journal of rehabilitation R&D

SN - 0748-7711

IS - 3

ER -